Autopsy report · NCT05116917

Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer.

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Based on the precpecified interim analysis the predictive probability was below 10% for the prespecified endpoint.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 year 11 months before it stopped.
19 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Herlev Hospital
Sponsor type: University, hospital or other
Conditions: Pancreatic Cancer
Interventions: Nivolumab; Ipilimumab; Influenza vaccine; SBRT
Participants: 19
Sites: 1
Countries: Denmark

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.